Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 16, 04 December 2023
Open
Access | Article
A comprehensive journey through AIDS: History, development, and treatment
* Author to whom correspondence should be addressed.
Abstract
Acquired immune deficiency syndrome (AIDS) is a disease that attacks the human immune system. From its first discovery to modern investigations about this disease and the viruses that cause it, AIDS went through the process of being viewed as deadly and mysterious to controllable and preventable. By studying the mechanism of human immunodeficiency virus (HIV) and discovering the route of transmission of AIDS, the danger of this disease is gradually controlled by pills and therapies. The HIV life cycle has been uncoded and people found ways to target the specific steps to hinder HIV replication. Antiretroviral therapies are invented and gradually perfected to control the infection of AIDS. Nevertheless, a specific cure and any form of vaccine for AIDS has still not been found by humans. Several modern cases exhibited possible solutions to HIV infection while bringing more controversies and investigations. This review summarized the history and development of AIDS studies and its treatment, to possible future methods that could completely cure this disease.
Keywords
AIDS, HIV, Antiretroviral Therapy, AIDS Treatment
References
1. Cisneros, L. (2021) 40 Years of AIDS: A Timeline of the Epidemic | UC San Francisco.
2. Hamilton, W. et al. (2001) ‘The origins of acquired immune deficiency syndrome viruses: where and when?’, Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 356(1410), pp. 867–876.
3. Kirchhoff, F. (2013) ‘HIV Life Cycle: Overview’, in T.J. Hope, M. Stevenson, and D. Richman (eds) Encyclopedia of AIDS. New York, NY: Springer New York, pp. 1–9.
4. Swanson, C.M. and Malim, M.H. (2008) ‘SnapShot: HIV-1 proteins’, Cell, 133(4), pp. 742.
5. Goto, T., Nakai, M. and Ikuta, K. (1998) ‘The life-cycle of human immunodeficiency virus type 1’, Micron, 29(2), pp. 123–138.
6. Antiretroviral Drug Discovery and Development | NIH: National Institute of Allergy and Infectious Diseases (2018).
7. Fischl, M.A. et al. (1987) ‘The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex’, New England Journal of Medicine, 317(4), pp. 185–191.
8. Carpenter, C.C. (1996) ‘Antiretroviral therapy for HIV infection in 1996’, JAMA, 276(2), p. 146.
9. Carpenter, C.C.J., et al. (2000) ‘Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society–USA Panel’, JAMA, 283(3), pp. 381–390.
10. Pharm.D., F.J.P. (2006) An update and review of Antiretroviral therapy.
11. Eggleton, J.S. and Nagalli, S. (2020) Highly Active Antiretroviral Therapy (HAART), Europe PMC.
12. Carr, A. and Cooper, D.A. (2000) ‘Adverse effects of antiretroviral therapy’, The Lancet, 356(9239), pp. 1423–1430.
13. Chesney, M.A. (2000) ‘Factors Affecting Adherence to Antiretroviral Therapy’, Clinical Infectious Diseases, 30(Supplement_2), pp. S171–S176.
14. Cohen, J. (2014) How did the ‘Berlin patient’ rid himself of HIV? Science.
15. Siliciano, J.D. and Siliciano, R.F. (2014) ‘Rekindled HIV infection’, Science, 345(6200), pp. 1005–1006.
16. Cyranoski, D. and Ledford, H. (2018) Genome-edited baby claim provokes international outcry, Nature News.
17. Cohen, J. (2019) Did CRISPR help—or harm—the first-ever gene-edited babies? Science.
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Modern Medicine and Global Health
- ISBN (Print)
- 978-1-83558-195-7
- ISBN (Online)
- 978-1-83558-196-4
- Published Date
- 04 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/16/20240538
- Copyright
- 04 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited